Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.04 EUR
34.26 M EUR
426.52 M EUR
32.58 M
About TransMedics Group, Inc.
Sector
Industry
CEO
Waleed H. Hassanein
Website
Headquarters
Andover
Founded
1998
FIGI
BBG01TNWMD97
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
12/5/24 - $tmdx - I'm back... buying sub $7012/5/24 :: VROCKSTAR :: NASDAQ:TMDX
I'm back... buying sub $70
- check out last post when i opportunistically bot this thing
- some Q's on last call ppl pointing out about "seasonality" being a bit sus. interesting. yeah CEO did act a bit defensive and i don't have context or know the chad
- but
Catching the TransMedics Group - $TMDX Falling KnifeTransMedics Group - NASDAQ:TMDX
For current and new shareholders here is your buying range for this company.
This could be the bounce that sends us back towards ATH's. But, if we were to fall lower I think it would be capped out around the 200MA.
DCA Buying Range: $55-$90
AVP GAP Fill to $13
TMDXNASDAQ:TMDX is likely heading lower to complete the impulse in the wave C of a running flat. I will start buying within the range $60-70.
There are two typical dimensions for the wave C of a flat - wC=wA or times 1,618.
Zooming in the daily/ 4h frame - there is a clear impulsive move down, that is
Call the TransMedicsInteresting stock, the high growth that propelled it to a 600% plus gain is slowing down. Management claim it’s due to seasonal pressure, not sure if I can believe there’s a season for organ donors but now I know there is!
We’ve since had a 50% haircut in the last month. It’s going to be a turbulen
10/30/24 - $tmdx - Buying 11/15 C's sub $8510/30/24 :: VROCKSTAR :: NASDAQ:TMDX
Buying 11/15 C's sub $85
- this price action looks VERY similar to all the stonks that are getting rekt beyond the 25% threshold. it's incredible how similarly the mkt treats these things. by mkt i mean the AGI that controls us all at this pt and nobody wants
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of 1TMDX is 79.94 EUR — it has increased by 0.18% in the past 24 hours. Watch TRANSMEDICS GROUP INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange TRANSMEDICS GROUP INC stocks are traded under the ticker 1TMDX.
1TMDX stock has risen by 1.52% compared to the previous week, the month change is a 1.52% rise, over the last year TRANSMEDICS GROUP INC has showed a 1.52% increase.
We've gathered analysts' opinions on TRANSMEDICS GROUP INC future price: according to them, 1TMDX price has a max estimate of 110.00 EUR and a min estimate of 70.40 EUR. Watch 1TMDX chart and read a more detailed TRANSMEDICS GROUP INC stock forecast: see what analysts think of TRANSMEDICS GROUP INC and suggest that you do with its stocks.
1TMDX reached its all-time high on Apr 28, 2025 with the price of 82.94 EUR, and its all-time low was 78.74 EUR and was reached on Apr 29, 2025. View more price dynamics on 1TMDX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1TMDX stock is 0.18% volatile and has beta coefficient of 1.02. Track TRANSMEDICS GROUP INC stock price on the chart and check out the list of the most volatile stocks — is TRANSMEDICS GROUP INC there?
Yes, you can track TRANSMEDICS GROUP INC financials in yearly and quarterly reports right on TradingView.
TRANSMEDICS GROUP INC is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
1TMDX earnings for the last quarter are 0.18 EUR per share, whereas the estimation was 0.15 EUR resulting in a 19.06% surprise. The estimated earnings for the next quarter are 0.24 EUR per share. See more details about TRANSMEDICS GROUP INC earnings.
TRANSMEDICS GROUP INC revenue for the last quarter amounts to 117.49 M EUR, despite the estimated figure of 105.85 M EUR. In the next quarter, revenue is expected to reach 114.31 M EUR.
1TMDX net income for the last quarter is 6.62 M EUR, while the quarter before that showed 3.79 M EUR of net income which accounts for 74.93% change. Track more TRANSMEDICS GROUP INC financial stats to get the full picture.
No, 1TMDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 4, 2025, the company has 728 employees. See our rating of the largest employees — is TRANSMEDICS GROUP INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TRANSMEDICS GROUP INC EBITDA is 55.40 M EUR, and current EBITDA margin is 12.97%. See more stats in TRANSMEDICS GROUP INC financial statements.
Like other stocks, 1TMDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRANSMEDICS GROUP INC stock right from TradingView charts — choose your broker and connect to your account.